MAPT and Insulin resistance: Additionally, it focuses on the molecular mechanism of brain insulin resistance that may involve either increased serine phosphorylation of IRS-1 protein (i.e., IRS-1 inhibition) and elevated degradation of IRS protein as common pathological mechanisms, including aggregation of toxic Aβ plaques, tau hyperphosphorylation and autophagy.